Figure 1.
General design strategy for an HP-erythromycin conjugate prodrug 1 that mitigates iron-binding, alters physicochemical properties and aims to enhance translational potential of HP antibacterial agents.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.